株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓欠陥閉鎖装置の世界市場:2019年〜2023年

Global Heart Defect Closure Devices Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 310043
出版日 ページ情報 英文 137 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.21円で換算しております。
Back to Top
心臓欠陥閉鎖装置の世界市場:2019年〜2023年 Global Heart Defect Closure Devices Market 2019-2023
出版日: 2019年02月06日 ページ情報: 英文 137 Pages
概要

心房粗動(AF)は、臨床診療において最も一般的に遭遇する不整脈です。特に脳卒中および心不全の罹患率の増加と死亡率に関連しています。 AFは世界的に公衆衛生上の大きな負担となりつつあり、特に発展途上国では急速に増加する高齢者人口のためにその罹患率が増加すると予想されています。高血圧(BP)、肥満、糖尿病、心不全、虚血性心疾患、慢性腎臓病(CKD)、アルコールの大量消費など、AFの他の危険因子も増加しています。それ故、AFの罹患率の上昇は、LAA閉鎖療法に対する需要を増大させ、世界の心臓欠陥閉鎖装置市場の成長を牽引するでしょう。 Technavioのアナリストは、世界の心臓欠陥閉鎖装置市場が2023年までに29%以上のCAGRで成長すると予測しています。

当レポートでは、世界の心臓欠陥閉鎖装置市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年〜2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 比較:製品別市場規模および予測(2018年〜2023年)
  • LAA閉鎖装置
  • PFO閉鎖装置
  • ASD閉鎖装置
  • その他
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年〜2023年)
  • 欧州
  • 北米
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第10章 市場動向

  • 心臓欠陥閉鎖装置の地理的範囲を拡大するための臨床試験の増加
  • 生体吸収性オクルーダの研究開発への関心の高まり
  • 心臓欠陥閉鎖処置における3D画像の活用

第11章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Lifetech Scientific
  • WL Gore & Associates, Inc.

第13章 付録

  • 調査方法
  • 略語のリスト
図表
  • Exhibit 01: Years in consideration
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: LAA closure devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: LAA closure devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: PFO closure devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: PFO closure devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: ASD closure devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: ASD closure devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Other heart defect closure devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Other heart defect closure devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Market share by geography 2018-2023 (%)
  • Exhibit 31: Geographic comparison
  • Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Key leading countries
  • Exhibit 42: Market opportunity
  • Exhibit 43: Decision framework
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Abbott - Vendor overview
  • Exhibit 51: Abbott - Business segments
  • Exhibit 52: Abbott - Organizational developments
  • Exhibit 53: Abbott - Geographic focus
  • Exhibit 54: Abbott - Segment focus
  • Exhibit 55: Abbott - Key offerings
  • Exhibit 56: Abbott - Key customers
  • Exhibit 57: AtriCure, Inc. - Vendor overview
  • Exhibit 58: AtriCure, Inc. - Product segments
  • Exhibit 59: AtriCure, Inc. - Organizational developments
  • Exhibit 60: AtriCure, Inc. - Geographic focus
  • Exhibit 61: AtriCure, Inc. - Segment focus
  • Exhibit 62: AtriCure, Inc. - Key offerings
  • Exhibit 63: AtriCure, Inc. - Key customers
  • Exhibit 64: Boston Scientific Corporation - Vendor overview
  • Exhibit 65: Boston Scientific Corporation - Business segments
  • Exhibit 66: Boston Scientific Corporation - Organizational developments
  • Exhibit 67: Boston Scientific Corporation - Geographic focus
  • Exhibit 68: Boston Scientific Corporation - Segment focus
  • Exhibit 69: Boston Scientific Corporation - Key offerings
  • Exhibit 70: Boston Scientific Corporation - Key customers
  • Exhibit 71: Cardia, Inc. - Vendor overview
  • Exhibit 72: Cardia, Inc. - Product segments
  • Exhibit 73: Cardia, Inc. - Key offerings
  • Exhibit 74: Cardia, Inc. - Key customers
  • Exhibit 75: Lifetech Scientific - Vendor overview
  • Exhibit 76: Lifetech Scientific - Business segments
  • Exhibit 77: Lifetech Scientific - Organizational developments
  • Exhibit 78: Lifetech Scientific - Geographic focus
  • Exhibit 79: Lifetech Scientific - Segment focus
  • Exhibit 80: Lifetech Scientific - Key offerings
  • Exhibit 81: Lifetech Scientific - Key customers
  • Exhibit 82: W. L. Gore & Associates, Inc. - Vendor overview
  • Exhibit 83: W. L. Gore & Associates, Inc. - Product segments
  • Exhibit 84: W. L. Gore & Associates, Inc. - Organizational developments
  • Exhibit 85: W. L. Gore & Associates, Inc. - Key offerings
  • Exhibit 86: W. L. Gore & Associates, Inc. - Key customers
  • Exhibit 87: Validation techniques employed for market sizing
  • Exhibit 88: List of abbreviations
目次
Product Code: IRTNTR30831

About this market

AF is the most commonly encountered arrhythmia in clinical practice. It is associated with increased morbidity, especially stroke and heart failure, and mortality. AF is becoming a major public health burden across the world, and its prevalence is expected to increase due to the rapidly growing geriatric population, especially in developing countries. Other risk factors of AF such as high blood pressure (BP), obesity, diabetes, heart failure, ischemic heart disease, chronic kidney disease (CKD), and the heavy consumption of alcohol are also on the rise. Hence, the rising prevalence of AF will increase the demand for LAA closure therapy. which will drive the growth of the global heart defect closure devices market. Technavio's analysts have predicted that the heart defect closure devices market will register CAGR of over 29% by 2023.

Market Overview

Technological advances in heart defect closure

There had been several significant technological advances in all forms of cardiovascular care. especially in the treatment of structural heart disease, in the last decade. The advances in catheterization techniques, medical imaging, and devices have increased the adoption of minimally invasive procedures. Therefore, interventional cardiology procedures have now become the standard of care to treat ASD and PFO.

Shortage of skilled surgeons to perform heart defect closure procedures

There is a global shortage of cardiologists, including general cardiologists, electrophysiologists: interventional cardiologists, both coronary and peripheral, and pediatric cardiologists. This shortage is attributed to the aging cardiology community, limited growth in fellowship positions, increasing burden of cardiovascular diseases (CVDs): and evolving health care reforms.

For the detailed list of factors that will drive and challenge the growth of the heart defect closure devices market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • LAA closure devices - Market size and forecast 2018-2023
  • PFO closure devices - Market size and forecast 2018-2023
  • ASD closure devices - Market size and forecast 2018-2023
  • Other heart defect closure devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Increasing number of clinical trials to expand geographic coverage of heart defect closure devices
  • Rising focus on R&D of bioabsorbable occluders
  • Use of 3D imaging in heart defect closure procedures

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Lifetech Scientific
  • W. L. Gore & Associates, Inc.

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations
Back to Top